An increased frequency of intratumoral FOXP3+ Tregs and inhibitory cytokines such as IL-10 and TGF-β was noted in bladder cancer patients compared to the healthy population [12, 22–23, 39]. This evidence concerns the gene FOXP3 and urinary bladder carcinoma.